Ads
related to: waldenstrom's disease
Search results
Results From The WOW.Com Content Network
It is characterized by having high levels of a circulating antibody, immunoglobulin M (IgM), which is made and secreted by the cells involved in the disease. Waldenström macroglobulinemia is an "indolent lymphoma" (i.e., one that tends to grow and spread slowly) and a type of lymphoproliferative disease which shares clinical characteristics ...
Bing–Neel syndrome (BNS) is an extremely rare neurologic complication of Waldenström macroglobulinemia (WM), which is a chronic lymphoproliferative disorder. [1] There's no clear definition of BNS but what is known so far is that unlike WM, It involves the central nervous system (CNS), infiltrated by differentiated malignant B cells and by having hyperglobulinemia. [2]
The incidence of Waldenstrom’s macroglobulinemia ranges from 0.36 1, 2 to 0.57 3 per 100,000 people in the United States or approximately 1,200 to 1,900 annually. With a median disease duration approaching 10 years, 4 approximately 12,000 to 19,000 patients are living with Waldenstrom’s macroglobulinemia in the United States. Recommended ...
In the study, 75.6% of patients with Waldenstrom's macroglobulinemia (WM) saw cancer decrease in size or disappear after treatment with Cellectar's therapy iopofosine.
Jan G. Waldenström (undated) Jan Gösta Waldenström (17 April 1906 – 1 December 1996) was a Swedish doctor of internal medicine, who first described the disease that bears his name, Waldenström macroglobulinemia.
What is Waldenstrom's macroglobulinemia? ... So that weighs heavily in every decision I make," Turner told People of the disease. "It was like 10 tons of concrete were just dropped on me. And I ...